Myriad Genetics buys medical diagnostics company Crescendo for $270 million cash
February 04, 2014 at 18:28 PM EST
Myriad Genetics Inc. will buy South San Francisco's Crescendo Bioscience Inc. for $270 million cash, the companies said Tuesday...